Safety and Efficacy Study of Chemotherapy Plus Apatinib as Second-line Therapy in Metastatic Colorectal Cancer

Stopped Inadequate patient enrollment

Conditions

• Colorectal Cancer
• Chemotherapy
• Angiogenesis

Interventions

• DRUG: Chemotherapy + Apatinib

Sponsor

Union Hospital, Tongji Medical College, Huazhong University of Science and Technology